Search Results

A shortfall of cannabis in Canada’s regulated market took a toll on the international sales of an industry leader, Aurora Cannabis, according to the company.

More than 750 kilograms of medical cannabis flower was imported to Germany in the first quarter of this year, putting the country on pace to import about the same amount in 2019 as it did last year – 3,000 kilograms.

Canadian licensed producer TerrAscend has received EU-GMP certification, a requirement for any business looking to sell its medical cannabis products in the European Union.

With Europe fast becoming a cornerstone in the global medical marijuana industry, business leaders from dozens of countries descended on Copenhagen, Denmark, to discuss emerging opportunities in the burgeoning market.

The Netherlands is taking steps to boost the country’s medical cannabis cultivation, a move that could end Dutch cultivator Bedrocan’s longstanding monopoly position for supplying the country.

Despite a sharp increase in revenue, Ontario-based Aphria’s third-quarter 2018 profit of 12.9 million Canadian dollars ($9.6 million) turned into a net loss of CA$108.2 million for the third quarter of fiscal 2019.

Here are some notable stories and events to watch for in the coming days.